ENTX
Entera Bio Ltd
2.90$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -85.2% | +0.0% | -18.9% | +70.0% | -58.8% | +23.8% | -3.8% | +342.0% | -29.0% | -30.6% | +28.4% | +17.9% | -58.8% | -35.3% | -81.8% | +75.0% | -100.0% | – | – | – | -100.0% | – | -26.3% | +95.2% | -48.8% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | -35.5% | +170.0% | -61.1% | -26.2% | +0.0% | +238.7% | -30.5% | +35.6% | -34.3% | +187.7% | -71.1% | -38.9% | -81.8% | +300.0% | -41.7% | +7.1% | -6.7% | -7.1% | +0.0% | +269.2% | -12.5% | +95.2% | -48.8% | -83.3% | +14.3% | -12.5% | +0.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -97.6% | +0.0% | +66.7% | -130.0% | – | – | -9.5% | +510.5% | -27.6% | -88.1% | +650.0% | -129.3% | – | -21.4% | -81.8% | -600.0% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | -14.0% | -19.7% | -6.1% | -32.4% | +166.5% | +167.4% | -39.0% | +2.3% | +13.7% | -0.9% | -30.6% | +26.4% | +10.0% | -18.3% | +25.3% | -20.1% | -26.8% | -4.4% | +9.2% | +44.3% | +48.2% | -35.6% | -17.5% | +1.4% | -5.5% | -31.3% | +30.2% | +13.6% | -27.2% | -26.8% | +50.4% | +36.0% | -18.7% | -6.5% | +35.4% | +7.6% | +5.1% | +30.6% | +42.6% | – | |
| – | -16.6% | +242.1% | +65.3% | -0.8% | +39.4% | -61.8% | -67.6% | +159.2% | -12.4% | +13.7% | -40.5% | +70.9% | +42.0% | -15.4% | +19.1% | -46.1% | +49.0% | +6.0% | +4.2% | +12.5% | -3.5% | +46.6% | -13.4% | -22.3% | +19.2% | -25.7% | -12.3% | -9.4% | -5.4% | +36.4% | -18.0% | +41.9% | -26.4% | +26.8% | -20.3% | +40.5% | -17.9% | -2.7% | +5.7% | – | |
| – | -14.9% | +51.4% | +62.0% | -7.2% | +58.0% | -5.3% | -67.4% | +111.4% | +4.1% | +3.6% | -34.0% | +40.1% | +22.0% | -17.0% | +22.6% | -31.4% | -1.0% | +0.5% | +6.5% | -221.9% | – | -6.3% | -15.3% | -12.1% | +7.3% | -28.1% | +5.3% | +2.4% | -17.8% | +4.5% | +6.1% | +39.0% | -22.6% | +9.7% | +4.1% | +21.7% | -6.3% | +16.1% | +29.2% | – | |
| – | – | – | – | – | – | -122.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -228.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | -100.0% | – | – | +15.0% | +0.0% | -30.4% | +0.0% | +18.8% | +73.7% | -51.5% | – | – | -55.2% | +284.6% | – | – | – | – | – | +36.4% | -86.7% | +253,125.0% | -78.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -424.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | -180.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -14,695.0% | – | -247.8% | – | +18.8% | +73.7% | -51.5% | -243.8% | – | -55.2% | +438.5% | -120.0% | – | – | -1,500.0% | – | – | – | -123.7% | – | – | -98.8% | +7,089.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -424.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | -177.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -179.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.